Background: Stereotactic arrhythmia radiotherapy (STAR) has been proposed recently in patients with refractory ventricular tachycardia (VT).
Objectives: The purpose of this study was to describe the efficacy and safety of STAR in the Czech Republic.
Methods: VT patients were recruited in 2 expert centers after at least 1 previously failed catheter ablation (CA).